MSCs from Amniotic Membrane for Chronic Kidney Disease

How Stem Plus applies MSCs from Amniotic Membrane within a personalised Chronic Kidney Disease protocol — in the EU, from €3,000–€8,000.

For Chronic Kidney Disease, MSCs from Amniotic Membrane are selected for their specific regenerative profile and delivered under GMP conditions. The protocol combines cell type, dose and delivery route to match your individual assessment.

This is one of several cell options for Chronic Kidney Disease. Compare them on the Chronic Kidney Disease overview, or see the MSCs from Amniotic Membrane page.

GMP-certified MSCs from Amniotic Membrane, characterised and viability-tested
Physician-led Chronic Kidney Disease protocol
Transparent €3,000–€8,000 pricing
Remote follow-up worldwide

Educational information; investigational for several conditions. Outcomes vary.

European-grade cell therapy, without European prices.

GMP-certified regenerative medicine in the heart of the EU — from €3,000–8,000, a fraction of US or German pricing. Personalised protocols for international patients from 50+ countries.

Free medical review

MSCs from Amniotic Membrane for Chronic Kidney Disease

Related

European-grade cell therapy, without European prices.